top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
R3 Vascular Raises $87M in Series B Financing
Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in...
Atai Life Sciences Announces Leadership Transition
New York and Berlin, May 15, 2024 (Globe Newswire) -- Atai Life Sciences, a clinical-stage biopharmaceutical company, has unveiled its...
Lilly Bolsters Radiopharmaceuticals Portfolio Through $1.1B Collaboration Deal with Aktis Oncology
Indianapolis, IN, May 21, 2024 (msn.com) -- In a strategic move to bolster its presence in the radiopharmaceuticals domain, Eli Lilly...
Bolt Biotherapeutics Appoints Willie Quinn as Chief Executive Officer
Redwood City, CA, May 14, 2024 (Globe Newswire) -- Bolt Biotherapeutics, a biopharmaceutical firm headquartered in Redwood City,...
Biogen Bolsters Rare Disease Portfolio with $1.8B Acquisition of Human Immunology Biosciences
Cambridge, MA, May 22, 2024 (Reuters) -- In a strategic move aimed at reinforcing its portfolio of rare disease therapeutics, Biogen...
BridgeBio Pharma Secures $200M Private Financing to Propel Oncology Portfolio Development
Palo Alto, CA, May 2, 2024 (Globe Newswire) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) recently completed a $200M private financing round...
Brian Blaser appointed as QuidelOrtho's President and CEO
San Diego, CA, May 2, 2024 (QuidelOrtho) -- Brian J. Blaser has been appointed as the new President and CEO of QuidelOrtho. Most...
Novartis to buy Mariana Oncology for $1B upfront
Watertown, MA, May 2, 2024 (finance.yahoo.com) -- Novartis is acquiring Mariana Oncology, a biotech firm specializing in targeted...
Cagent Vascular appoints Brian Walsh as CEO
Wayne, PA, May 7, 2024 (Business Wire) -- Brian Walsh, previously at Carl Zeiss, has been appointed as the new Chief Executive Officer...
ONO Pharmaceutical to Acquire Deciphera Pharmaceuticals in $2.4B Deal
Waltham, MA and Osaka, Japan, April 29, 2024 (PRNewswire) -- ONO Pharmaceutical, Co., Ltd., and Deciphera Pharmaceuticals, Inc., have...
Weight-Loss Drug Startup Metsera Launches with $290M Funding
NY, NY, April 18, 2024 (Business Wire) -- Metsera, Inc., a pioneering player in the clinical-stage biopharmaceutical realm focusing on...
Flare Therapeutics Names Dr. Douglas Manion as New CEO
Cambridge, MA, April 23 2024 (PRNewswire) -- Flare Therapeutics Inc. has undergone a notable leadership transition with the selection...
Incyte Corp. to Acquire Escient Pharmaceuticals for $750M
Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus...
Biopharmaceutical Leader Thomas Smart Takes Helm as CEO at Actym Therapeutics
Berkeley, CA, April 24, 2024 (PRNewswire) -- Actym Therapeutics announced the appointment of Thomas Smart as its new Chief Executive...
Steris Sells Dental Segment to Peak Rock affiliate in $787M Deal
Austin, TX, April 19, 2024 (Lexology) -- Steris has entered into a contract to sell its dental division to private equity firm Peak...
Alterome Therapeutics Raises $132M Led by Goldman Sachs for Precision Oncology Initiatives
San Diego, CA, April 3, 2024 (Reuters) -- Alterome Therapeutics announced that it has successfully secured $132 million. Spearheaded by...
Zura Bio Announces Robert Lisicki as CEO and Director
Henderson, NV, April 8, 2024 (Zura Bio) -- Zura Bio, a company focused on advancing treatments for autoimmune and inflammatory...
Obsidian Therapeutics Secures $160.5M Series C Funding for Advancement of OBX-115 Clinical Trials
Cambridge, MA, April 3, 2024 (Business Wire) -- Obsidian Therapeutics, Inc., a cutting-edge clinical-stage biotechnology company...
Wolfgang Wienand Named New CEO of Lonza
Basel, Switzerland, April 2, 2024 (Lonza) -- In a strategic move, Lonza has announced the appointment of Wolfgang Wienand as its new...
J&J buys Shockwave for $13.1B
New Brunswick, NJ and Santa Clara, CA, April 5, 2024 (JNJ) -- Johnson & Johnson has entered into an agreement to purchase Shockwave...
bottom of page